vs
FLEXSTEEL INDUSTRIES INC（FLXS）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
FLEXSTEEL INDUSTRIES INC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.5倍（$115.1M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 1.0%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 1.9%）
Flexsteel Industries Inc是一家总部位于美国的家具制造商，设计、生产并销售各类软垫住宅家具、商用家具及酒店家具，主要面向北美市场运营，通过广泛的分销网络服务终端消费者、零售合作伙伴及企业客户。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
FLXS vs PBYI — 直观对比
营收规模更大
FLXS
是对方的1.5倍
$75.5M
营收增速更快
PBYI
高出26.7%
1.0%
两年增速更快
PBYI
近两年复合增速
1.9%
损益表 — Q1 FY2027 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $115.1M | $75.5M |
| 净利润 | $20.4M | — |
| 毛利率 | 22.6% | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 17.7% | — |
| 营收同比 | 1.0% | 27.7% |
| 净利润同比 | 116.0% | — |
| 每股收益（稀释后） | $1.14 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FLXSPBYI
| Q3 26 | $115.1M | — | ||
| Q4 25 | $118.2M | $75.5M | ||
| Q3 25 | $110.4M | $54.5M | ||
| Q2 25 | $114.6M | $52.4M | ||
| Q1 25 | $114.0M | $46.0M | ||
| Q4 24 | $108.5M | $59.1M | ||
| Q3 24 | $104.0M | $80.5M | ||
| Q2 24 | $110.8M | $47.1M |
净利润FLXSPBYI
| Q3 26 | $20.4M | — | ||
| Q4 25 | $6.6M | — | ||
| Q3 25 | $7.3M | $8.8M | ||
| Q2 25 | $10.7M | $5.9M | ||
| Q1 25 | $-3.7M | $3.0M | ||
| Q4 24 | $9.1M | — | ||
| Q3 24 | $4.1M | $20.3M | ||
| Q2 24 | $4.9M | $-4.5M |
毛利率FLXSPBYI
| Q3 26 | 22.6% | — | ||
| Q4 25 | 22.7% | 69.3% | ||
| Q3 25 | 23.5% | 77.7% | ||
| Q2 25 | 23.9% | 76.5% | ||
| Q1 25 | 22.2% | 77.1% | ||
| Q4 24 | 21.0% | 76.4% | ||
| Q3 24 | 21.5% | 63.9% | ||
| Q2 24 | 21.3% | 77.4% |
营业利润率FLXSPBYI
| Q3 26 | — | — | ||
| Q4 25 | 7.6% | 22.7% | ||
| Q3 25 | 8.1% | 17.6% | ||
| Q2 25 | 12.2% | 12.7% | ||
| Q1 25 | -4.4% | 8.7% | ||
| Q4 24 | 10.7% | 22.6% | ||
| Q3 24 | 5.8% | 27.4% | ||
| Q2 24 | 6.9% | -4.6% |
净利率FLXSPBYI
| Q3 26 | 17.7% | — | ||
| Q4 25 | 5.6% | — | ||
| Q3 25 | 6.6% | 16.2% | ||
| Q2 25 | 9.3% | 11.2% | ||
| Q1 25 | -3.3% | 6.5% | ||
| Q4 24 | 8.3% | — | ||
| Q3 24 | 4.0% | 25.2% | ||
| Q2 24 | 4.4% | -9.6% |
每股收益（稀释后）FLXSPBYI
| Q3 26 | $1.14 | — | ||
| Q4 25 | $1.18 | $0.26 | ||
| Q3 25 | $1.31 | $0.17 | ||
| Q2 25 | $1.90 | $0.12 | ||
| Q1 25 | $-0.71 | $0.06 | ||
| Q4 24 | $1.62 | $0.40 | ||
| Q3 24 | $0.74 | $0.41 | ||
| Q2 24 | $0.87 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $57.3M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $185.3M | $130.3M |
| 总资产 | $290.2M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资FLXSPBYI
| Q3 26 | $57.3M | — | ||
| Q4 25 | $36.8M | $97.5M | ||
| Q3 25 | $38.6M | $94.4M | ||
| Q2 25 | $40.0M | $96.0M | ||
| Q1 25 | $22.6M | $93.2M | ||
| Q4 24 | $11.8M | $101.0M | ||
| Q3 24 | $5.7M | $96.7M | ||
| Q2 24 | $4.8M | $96.8M |
总债务FLXSPBYI
| Q3 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益FLXSPBYI
| Q3 26 | $185.3M | — | ||
| Q4 25 | $178.9M | $130.3M | ||
| Q3 25 | $172.2M | $115.3M | ||
| Q2 25 | $167.9M | $104.7M | ||
| Q1 25 | $158.1M | $97.1M | ||
| Q4 24 | $161.9M | $92.1M | ||
| Q3 24 | $154.7M | $71.1M | ||
| Q2 24 | $150.4M | $48.5M |
总资产FLXSPBYI
| Q3 26 | $290.2M | — | ||
| Q4 25 | $290.2M | $216.3M | ||
| Q3 25 | $281.5M | $202.9M | ||
| Q2 25 | $282.5M | $194.9M | ||
| Q1 25 | $266.1M | $196.2M | ||
| Q4 24 | $271.5M | $213.3M | ||
| Q3 24 | $268.7M | $220.7M | ||
| Q2 24 | $274.5M | $205.0M |
负债/权益比FLXSPBYI
| Q3 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.2M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 1.33× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流FLXSPBYI
| Q3 26 | $27.2M | — | ||
| Q4 25 | $1.0M | $14.4M | ||
| Q3 25 | $4.1M | $9.7M | ||
| Q2 25 | $15.6M | $14.1M | ||
| Q1 25 | $12.3M | $3.6M | ||
| Q4 24 | $6.7M | $15.6M | ||
| Q3 24 | $2.4M | $11.0M | ||
| Q2 24 | $7.5M | $1.0M |
自由现金流FLXSPBYI
| Q3 26 | — | — | ||
| Q4 25 | $-735.0K | $14.4M | ||
| Q3 25 | $2.8M | $9.7M | ||
| Q2 25 | $15.1M | $14.1M | ||
| Q1 25 | $10.9M | $3.6M | ||
| Q4 24 | $5.8M | $15.6M | ||
| Q3 24 | $2.0M | $11.0M | ||
| Q2 24 | $7.1M | $1.0M |
自由现金流率FLXSPBYI
| Q3 26 | — | — | ||
| Q4 25 | -0.6% | 19.1% | ||
| Q3 25 | 2.5% | 17.7% | ||
| Q2 25 | 13.1% | 26.8% | ||
| Q1 25 | 9.6% | 7.7% | ||
| Q4 24 | 5.3% | 26.4% | ||
| Q3 24 | 1.9% | 13.7% | ||
| Q2 24 | 6.4% | 2.1% |
资本支出强度FLXSPBYI
| Q3 26 | — | — | ||
| Q4 25 | 1.5% | 0.0% | ||
| Q3 25 | 1.2% | 0.0% | ||
| Q2 25 | 0.5% | 0.0% | ||
| Q1 25 | 1.2% | 0.1% | ||
| Q4 24 | 0.8% | 0.0% | ||
| Q3 24 | 0.4% | 0.0% | ||
| Q2 24 | 0.4% | 0.0% |
现金转化率FLXSPBYI
| Q3 26 | 1.33× | — | ||
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.56× | 1.10× | ||
| Q2 25 | 1.46× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.58× | 0.54× | ||
| Q2 24 | 1.53× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
